Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits
- 25 April 2009
- Vol. 387 (1) , 147-156
- https://doi.org/10.1016/j.virol.2009.02.005
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccinesVirology, 2006
- Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 IsolateJournal of Virology, 2003
- Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic CellsThe Journal of Immunology, 2003
- Enhanced Immune Responses After DNA Vaccination with Combined Envelope Genes from Different HIV-1 SubtypesVirology, 2002
- Synergistic adjuvant activity of immunostimulatory DNA and oil/water emulsions for immunization with HIV p55 gag antigenVaccine, 2002
- Purification and Characterization of Oligomeric Envelope Glycoprotein from a Primary R5 Subtype B Human Immunodeficiency VirusJournal of Virology, 2002
- CpG Motif Identification for Veterinary and Laboratory Species Demonstrates That Sequence Recognition Is Highly ConservedAntisense and Nucleic Acid Drug Development, 2001
- Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosisEuropean Journal of Immunology, 2001
- The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable RegionJournal of Virology, 2001
- DNA Vaccination with the Human Immunodeficiency Virus Type 1 SF162ΔV2 Envelope Elicits Immune Responses That Offer Partial Protection from Simian/Human Immunodeficiency Virus Infection to CD8 + T-Cell-Depleted Rhesus MacaquesJournal of Virology, 2001